CY
CYPH
—
Nasdaq
Pharmaceuticals & Medical Research
Cypherpunk Technologies Inc.
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
108,3M USD
P/E
37,8x
EV / Rev
—
Div yield
—
Op margin
—
ROE
-91,5 %
Net margin
—
Debt / equity
—
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$0,66
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
CYPHERPUNK TECHNOLOGIES INC. is classified under Healthcare / Pharmaceuticals and appears not currently profitable on the latest normalized snapshot.
Business. CYPHERPUNK TECHNOLOGIES INC. (CYPH) is a biotechnology and medical research company engaged in pharmaceuticals and medical research activities. The firm operates within the Healthcare sector, specifically focusing on product-based revenue models typical of the industry. Headquartered in the United States, the company is listed on the Nasdaq stock exchange. No specific operating segments or geographic breakdowns are disclosed in the available data.
Classification99 %
SectorHealth Care
Industry groupPharmaceuticals & Medical Research
Generated · rules-based
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target0,90
Analyst recommendations
1 analysts · consensus BuyBuy1
Hold0
Sell0
12-month price target
0,90
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation→
37,8x
P/E
Analysts→
Buy
1 analysts · indicative
Ownership→
Vanguard Capital Management, LLC
largest disclosed fund holder
Profitability→
-91,5 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to CYPH. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Briefing · model-assisted
Cypherpunk Technologies Inc. (CYPH) has recorded its first notable holder change, with investor ID 466 adding 172,056 shares to their position as of June 30, 2024. This acquisition represents a portfolio weight of approximately 0.0000076% and a total value of $0.337 million. The signal was detected on June 20, 2026, marking the initial significant movement in ownership for the ticker. This development is particularly significant as it constitutes the first analysis for CYPH, meaning there is no prior basis for computing delta changes in holder activity. The addition of this position by investor ID 466 serves as the baseline for future monitoring of institutional or significant holder interest in the company. In terms of corporate structure, Cypherpunk Technologies Inc. currently lists one officer and has no analyst coverage or index memberships. The company’s shareholder base includes eight top holders, providing a limited but defined view of its ownership concentration. The absence of cross-source signals and material changes beyond this initial holder addition suggests that the market’s attention to CYPH is in its early stages. Investors should monitor subsequent filings, such as the 10-K and 10-Q reports from 2025 and 2026, to determine if this initial interest translates into broader market engagement or further capital inflows.
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
CYPHERPUNK TECHNOLOGIES INC. (CYPH) is a biotechnology and medical research company engaged in pharmaceuticals and medical research activities. The firm operates within the Healthcare sector, specifically focusing on product-based revenue models typical of the industry. Headquartered in the United States, the company is listed on the Nasdaq stock exchange. No specific operating segments or geographic breakdowns are disclosed in the available data.
Classification99 %
SectorHealth Care
Industry groupPharmaceuticals & Medical Research
AI synthesis
GENERATEDCYPHERPUNK TECHNOLOGIES INC. (CYPH) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.78 (rule-based classification). Capital structure on the latest snapshot: total assets 87,378,000 USD, total equity 84,375,000, short-term debt 0, long-term debt 0. Net cash position is approximately 6,689,000 USD. Self-calculated market cap is 182,392,335 USD (market_price × shares_outstanding_diluted). Profitability profile: revenue 0, gross profit 0, operating income -4,817,000, net income -77,166,000. Return on equity ~-91.5%. Return on assets ~-88.3%. Operating-cash-flow to net-income ratio is 0.04. Risk profile from automated assessment: liquidity risk high, dilution risk high. Flags: Diluted share count is materially above the basic share count.; Filings reference going-concern or substantial-doubt language.; Source documents mention dilution or offering risk.. Recent news context: [TRIGGER] 8-K: 8-K (sec_8k_material) on CYPH — filing_type=8-K; max_severity=critical; ignored_items=[]; material_items=['3.01']; all_items_found=['3.01']; severity_per_code={'3.01': 'critical'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001104659-26-085399). Additional context: 8-K: filing_type=8-K; max_severity=critical; ignored_items=[]; material_items=['3.01']; all_items_found=['3.01']; severity_per_code={'3.01': 'critical'}; contributing_watchers=sec_8k_material.
Cypherpunk Technologies Inc. (CYPH) has recorded its first notable holder change, with investor ID 466 adding 172,056 shares to their position as of June 30, 2024. This acquisition represents a portfolio weight of approximately 0.0000076% and a total value of $0.337 million. The signal was detected on June 20, 2026, marking the initial significant movement in ownership for the ticker. This development is particularly significant as it constitutes the first analysis for CYPH, meaning there is no prior basis for computing delta changes in holder activity. The addition of this position by investor ID 466 serves as the baseline for future monitoring of institutional or significant holder interest in the company. In terms of corporate structure, Cypherpunk Technologies Inc. currently lists one officer and has no analyst coverage or index memberships. The company’s shareholder base includes eight top holders, providing a limited but defined view of its ownership concentration. The absence of cross-source signals and material changes beyond this initial holder addition suggests that the market’s attention to CYPH is in its early stages. Investors should monitor subsequent filings, such as the 10-K and 10-Q reports from 2025 and 2026, to determine if this initial interest translates into broader market engagement or further capital inflows.
Key takeaways
- Return on equity is about -91.5%.
- Debt to equity is about 0.0x.
- [TRIGGER] 8-K: 8-K (sec_8k_material) on CYPH — filing_type=8-K; max_severity=critical; ignored_items=[]; material_items=['3.01']; all_items_found=['3.01']; severity_per_code={'3.01': 'critical'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001104659-26-085399)
- Companyfacts coverage was partial; recent filing facts backfilled property_and_equipment.
- CYPHERPUNK TECHNOLOGIES INC._ March 31, 2026 0001509745 --12-31 2026 Q1 false P3Y P60D 1 1 0001509745 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001509745 us-gaap:CommonStockMember cyph:AtMarketOfferingMember 2026-01-01 2026-03-31 0001509745 cyph:October2025PrivatePlacementMember 2025-10-06 2025-10-06 0001509745 us-gaap:RetainedEarningsMember 2026-03-31 0001509745 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001509745 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001509745 us-gaap:RetainedEarningsMember 2025-12-31 0001509745 us-gaap:ReceivablesFromStockholderMember 2025-12-31 0001509745 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001509745 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001509745 us-gaap:RetainedEarningsMember 2025-03-31 0001509745 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001509745 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001509745 us-gaap:RetainedEarningsMember 2024-12-31 0001509745 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001509745 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001509745 us-gaap:CommonStockMember 2026-03-31 0001509745 us-gaap:CommonStockMember 2025-12-31 0001509745 us-gaap:CommonStockMember 2025-03-31 0001509745 us-gaap:CommonStockMember 2024-12-31 0001509745 cyph:Equityincentiveplan2016and2022Member 2026-03-31 0001509745 cyph:EquityIncentivePlan2022Member 2022-06-16 0001509745 cyph:EquityIncentivePlan2025Member us-gaap:CommonStockMember 2025-12-15 0001509745 cyph:EquityIncentivePlan2025Member 2025-12-14 0001509745 cyph:EquityIncentivePlan2022Member 2023-06-16 2023-06-16 0001509745 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001509745 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001509745 us-gaap:RestrictedStockUnitsRSUMember 2025-10-01 2025-12-31 0001509745 srt:MinimumMember 2026-01-01 2026-03-31 0001509745 srt:MaximumMember 2026-01-01 2026-03-31 0001509745 us-gaap:SubsequentEventMember cyph:AtMarketOfferingMember 2026-04-01 2026-05-13 0001509745 2025-04-01 2025-06-30 0001509745 cyph:October2025PrivatePlacementMember 2025-10-08 2025-10-08 0001509745 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001509745 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001509745 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001509745 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001509745 cyph:WinklevossCapitalMember 2025-10-06 0001509745 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001509745 srt:WeightedAverageMember 2026-01-01 2026-03-31 0001509745 us-gaap:LicenseAndServiceMember 2026-03-31 0001509745 us-gaap:LicenseAndServiceMember 2025-12-31 0001509745 cyph:AtMarketOfferingMember 2026-03-31 0001509745 cyph:ZcashOpenDevelopmentLabMember 2026-01-01 2026-03-31 0001509745 us-gaap:SubsequentEventMember 2026-05-13 0001509745 cyph:EquityIncentivePlan2025Member 2025-12-15 0001509745 cyph:EquityIncentivePlan2022Member 2024-07-02 0001509745 cyph:WarrantsExercisableOn23rdJanuary2017Member 2026-03-31 0001509745 cyph:Warrants2019Member 2026-03-31 0001509745 cyph:October2025PreFundedWarrantsMember 2026-03-31 0001509745 cyph:October2025CommonWarrantsPlacementAgentWarrantsMember 2026-03-31 0001509745 cyph:October2025CommonWarrantsInvestorsMember 2026-03-31 0001509745 cyph:March2020CoverageWarrantsMember 2026-03-31 0001509745 cyph:October2025PrivatePlacementMember us-gaap:PrivatePlacementMember 2025-10-31 0001509745 cyph:October2025PrivatePlacementMember cyph:PlacementAgentWarrantsMember 2025-10-31 0001509745 cyph:October2025PreFundedWarrantsMember us-gaap:PrivatePlacementMember 2025-10-31 0001509745 cyph:October2025CommonWarrantsMember cyph:October2025PrivatePlacementMember 2025-10-06 0001509745 cyph:January2023SeriesXPreferredStockWarrantsMember cyph:SeriesXPreferredStockMember 2023-01-31 0001509745 cyph:January2023CommonStockWarrantsMember 2023-01-31 0001509745 us-gaap:FairValueInputsLevel1Member 2026-03-31 0001509745 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001509745 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001509745 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001509745 cyph:WarrantsToPurchaseCommonStockMember 2026-01-01 2026-03-31 0001509745 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001509745 cyph:WarrantsToPurchaseCommonStockMember 2025-01-01 2025-03-31 0001509745 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2026-01-01 2026-03-31 0001509745 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001509745 us-gaap:EmployeeStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2025-01-01 2025-03-31 0001509745 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2025-01-01 2025-03-31 0001509745 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001509745 us-gaap:AdditionalPaidInCapitalMember cyph:AtMarketOfferingMember 2026-01-01 2026-03-31 0001509745 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001509745 cyph:LicenseAndServiceAgreementsMember 2026-03-31 0001509745 2026-05-12 0001509745 cyph:October2025PreFundedWarrantsMember cyph:October2025PrivatePlacementMember 2025-10-06 0001509745 cyph:October2025PrivatePlacementMember 2025-10-06 0001509745 cyph:January2023SeriesXPreferredStockWarrantsMember cyph:SeriesXPreferredStockMember 2023-06-30 0001509745 us-gaap:ReceivablesFromStockholderMember 2026-01-01 2026-03-31 0001509745 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001509745 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001509745 cyph:EquityIncentivePlan2016Member 2017-01-20 2017-01-20 0001509745 us-gaap:PrivatePlacementMember 2025-10-01 2025-10-31 0001509745 cyph:CantorFitzgeraldAndCoMember 2026-03-31 0001509745 cyph:CantorFitzgeraldAndCoMember 2025-12-31 0001509745 cyph:CantorFitzgeraldAndCoMember 2025-11-30 0001509745 cyph:CantorFitzgeraldAndCoMember 2025-01-01 2025-12-31 0001509745 2025-06-23 2025-06-23 0001509745 2024-12-31 0001509745 cyph:CantorFitzgeraldAndCoMember 2026-01-01 2026-03-31 0001509745 2025-03-01 2025-03-31 0001509745 2025-07-01 2025-09-30 0001509745 2025-10-06 0001509745 2025-07-01 2025-07-31 0001509745 2025-01-01 2025-03-31 0001509745 2026-03-31 0001509745 srt:MinimumMember us-gaap:SubsequentEventMember 2026-04-01 2026-05-13 0001509745 srt:MaximumMember us-gaap:SubsequentEventMember 2026-04-01 2026-05-13 0001509745 us-gaap:SubsequentEventMember 2026-04-01 2026-05-13 0001509745 us-gaap:SubsequentEventMember 2026-01-01 2026-06-30 0001509745 cyph:September2021PreFundedWarrantsMember 2026-01-01 2026-03-31 0001509745 cyph:March2020PreFundedWarrantsMember 2026-01-01 2026-03-31 0001509745 cyph:April2024PreFundedWarrantsMember 2026-01-01 2026-03-31 0001509745 cyph:October2025PrivatePlacementMember cyph:PlacementAgentWarrantsMember 2025-10-01 2025-10-31 0001509745 cyph:October2025CommonWarrantsMember cyph:October2025PrivatePlacementMember 2025-10-06 2025-10-06 0001509745 2025-01-01 2025-12-31 0001509745 2025-03-31 0001509745 cyph:AtMarketOfferingMember 2026-01-01 2026-03-31 0001509745 2026-01-01 2026-03-31 0001509745 2025-12-31 iso4217:USD xbrli:pure iso4217:USD xbrli:shares xbrli:shares cyph:director cyph:Vote cyph:item cyph:segment Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Quarterly
Annual
QUARTERLYFiled 2026-03-31
Q4 2025 · Quarter highlights
Operating income -$4.8M.
Revenue—
Operating income-$4.8M
Net income-$77.2M
Free cash flow—
EPS—
Operating cash flow-$3.4M
Financials
Income statement
Revenue—
Gross profit—
Operating income-$4.8M
Net income-$77.2M
Balance sheet
Total assets$87.4M
Total liabilities$3.0M
Total equity$84.4M
Cash & equivalents$6.7M
Long-term debt—
Cash flow
Operating cash flow-$3.4M
CapEx—
Free cash flow—
SBC$2.1M
Highlights
- ▍Operating income -$4.8M
QUARTERLYFiled 2025-09-30
Q2 2025 · Quarter highlights
Operating income -$36.0M.
Revenue—
Operating income-$36.0M
Net income-$35.4M
Free cash flow—
EPS—
Operating cash flow-$37.3M
Financials
Income statement
Revenue—
Gross profit—
Operating income-$36.0M
Net income-$35.4M
Balance sheet
Total assets$11.4M
Total liabilities$8.7M
Total equity$2.7M
Cash & equivalents$9.7M
Long-term debt—
Cash flow
Operating cash flow-$37.3M
CapEx—
Free cash flow—
SBC$3.0M
Highlights
- ▍Operating income -$36.0M
QUARTERLYFiled 2025-06-30
Q1 2025 · Quarter highlights
Operating income -$32.8M.
Revenue—
Operating income-$32.8M
Net income-$32.1M
Free cash flow—
EPS—
Operating cash flow-$29.0M
Financials
Income statement
Revenue—
Gross profit—
Operating income-$32.8M
Net income-$32.1M
Balance sheet
Total assets$20.0M
Total liabilities—
Total equity$5.7M
Cash & equivalents$18.1M
Long-term debt—
Cash flow
Operating cash flow-$29.0M
CapEx—
Free cash flow—
SBC$2.7M
Highlights
- ▍Operating income -$32.8M
ANNUALFiled 2025-12-31
FY 2025 · Full-year highlights
Operating income -$41.1M.
Revenue—
Operating income-$41.1M
Net income$4.8M
Free cash flow—
EPS—
Operating cash flow-$43.9M
Financials
Income statement
Revenue—
Gross profit—
Operating income-$41.1M
Net income$4.8M
Balance sheet
Total assets$163.2M
Total liabilities$9.7M
Total equity$153.5M
Cash & equivalents$14.0M
Long-term debt—
Cash flow
Operating cash flow-$43.9M
CapEx—
Free cash flow—
SBC$4.9M
Highlights
- ▍Operating income -$41.1M
ANNUALFiled 2024-12-31
FY 2024 · Full-year highlights
Operating income -$70.1M.
Revenue—
Operating income-$70.1M
Net income-$67.6M
Free cash flow—
EPS—
Operating cash flow-$60.3M
Financials
Income statement
Revenue—
Gross profit—
Operating income-$70.1M
Net income-$67.6M
Balance sheet
Total assets$49.1M
Total liabilities—
Total equity$35.0M
Cash & equivalents$47.2M
Long-term debt—
Cash flow
Operating cash flow-$60.3M
CapEx—
Free cash flow—
SBC$5.5M
Highlights
- ▍Operating income -$70.1M
ANNUALFiled 2024-12-31
FY 2025 · Full-year highlights
Operating income -$70.1M.
Revenue—
Operating income-$70.1M
Net income-$67.6M
Free cash flow—
EPS—
Operating cash flow-$60.3M
Financials
Income statement
Revenue—
Gross profit—
Operating income-$70.1M
Net income-$67.6M
Balance sheet
Total assets$49.1M
Total liabilities$14.1M
Total equity$35.0M
Cash & equivalents$47.2M
Long-term debt—
Cash flow
Operating cash flow-$60.3M
CapEx—
Free cash flow—
SBC$5.5M
Highlights
- ▍Operating income -$70.1M
ANNUALFiled 2023-12-31
FY 2023 · Full-year highlights
Operating income -$87.0M.
Revenue—
Operating income-$87.0M
Net income-$81.4M
Free cash flow—
EPS—
Operating cash flow-$43.8M
Financials
Income statement
Revenue—
Gross profit—
Operating income-$87.0M
Net income-$81.4M
Balance sheet
Total assets$72.8M
Total liabilities$12.7M
Total equity$60.1M
Cash & equivalents$70.6M
Long-term debt—
Cash flow
Operating cash flow-$43.8M
CapEx—
Free cash flow—
SBC$5.1M
Highlights
- ▍Operating income -$87.0M
ANNUALFiled 2023-12-31
FY 2024 · Full-year highlights
Operating income -$87.0M.
Revenue—
Operating income-$87.0M
Net income-$81.4M
Free cash flow—
EPS—
Operating cash flow-$43.8M
Financials
Income statement
Revenue—
Gross profit—
Operating income-$87.0M
Net income-$81.4M
Balance sheet
Total assets$72.8M
Total liabilities—
Total equity$60.1M
Cash & equivalents$70.6M
Long-term debt—
Cash flow
Operating cash flow-$43.8M
CapEx—
Free cash flow—
SBC$5.1M
Highlights
- ▍Operating income -$87.0M
Valuation FY
Market price
$0,64
Market cap
$182.4M
Enterprise valueⓘ
$175.7M
P/Eⓘ
37.8x
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
2.2x
P / Tangible bookⓘ
2.2x
Tangible book
$84.4M
Net cashⓘ
$6.7M
Current ratioⓘ
27.3
Debt / equityⓘ
—
ROAⓘ
-88.3%
ROEⓘ
-91.5%
Cash conversionⓘ
4.0%
CapEx / revenueⓘ
—
SBC / revenueⓘ
—
Dilution ratioⓘ
79.0%
Revenue by segment
Business relationships
Business relationships6 disclosed relationships · 2 types · extracted from filings & disclosures
Partners1
Coinbase Global, Inc.COIN.OPartner90%Source ↗
Subsidiaries5
EX21:1f32b3105c84EX21:1f32b3105c84Subsidiarie97%
EX21:2ca5b8c43a98EX21:2ca5b8c43a98Subsidiarie97%
EX21:67859af27995EX21:67859af27995Subsidiarie97%
EX21:bbdca8ed95e8EX21:bbdca8ed95e8Subsidiarie97%
EX21:d30e4f264aceEX21:d30e4f264aceSubsidiarie97%
Supply chain
Vendors → CYPH ↔ Partners → Customers · click any node to drill
1 mention in 10-K0 from corporate websites0 from news dispatches
Updated 2026-06-24Peer comparison
Peer comparison8 peers · vs CYPH · multiples and returns
KL
KLAR—
KLAR.ST
—
—P/E
—
— vs self
Div yield
—
— vs self
ROE
—
— vs self
BN
BNTX—
Biontech SE
$92,25
23,3B USDP/E
—
— vs self
Div yield
—
— vs self
ROE
—
— vs self
EX
EXEL—
Exelixis Inc
$55,06
14,7B USDP/E
19,5x
— vs self
Div yield
—
— vs self
ROE
40,4 %
+131,9 vs self
MD
MDGL—
Madrigal Pharmaceuticals Inc
$482,00
11,0B USDP/E
—
— vs self
Div yield
—
— vs self
ROE
-47,8 %
+43,6 vs self
IN
INSM—
Insmed Inc
$107,46
23,0B USDP/E
—
— vs self
Div yield
—
— vs self
ROE
-160,2 %
-68,7 vs self
VC
VCYT—
Veracyte Inc
$45,30
3,6B USDP/E
55,5x
— vs self
Div yield
—
— vs self
ROE
5,1 %
+96,5 vs self
MD
MDXG—
Mimedx Group Inc
$4,27
636,0M USDP/E
11,1x
— vs self
Div yield
—
— vs self
ROE
18,9 %
+110,4 vs self
AV
AVIR—
Atea Pharmaceuticals Inc
$4,61
—P/E
—
— vs self
Div yield
—
— vs self
ROE
-57,5 %
+34,0 vs self
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
-0,51
Predicted surprise
+0,00
Beat probability
45 %
Analysts
1
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-07-26 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Full fiscal year~1 year ahead
Full fiscal year · our forecast vs guidance vs consensus
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,51 |
| Revenue | —no estimate | —no estimate | 0 USD |
| Operating income | —no estimate | —no estimate | -17,9M USD |
Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
Corporate eventM&A horizon
M&A probabilityconf 5 %
Probability
5 %
Base rate
3 %
Band
—
180-day horizon · target 2027-01-16 · 1,8× base rate
No acquirer candidates identified by the signal model.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution1 analysts
Strong buy0
Buy1
Hold0
Sell0
Strong sell0
12-month price target$0,90 · Median $0,90
Low $0,90High $0,90
Operating income · consensus-17,9M USD
EPS surprise
+113,7 %
reported vs consensus · beat
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$0,90
Mean$0,90
Median$0,90
High$0,90
Spot$0,64
+39.6 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskHigh
Liquidity riskHigh
Filing-based flags
- Diluted share count is materially above the basic share count.
- Filings reference going-concern or substantial-doubt language.
- Source documents mention dilution or offering risk.
Benchmarks vs cohort
ROE-91,5 %Bottom quartile
D/E0,00Above median
Cash Conv0,04Bottom quartile
Corporate actions / M&A
M&A probabilityconf —
Probability
5 %
Base rate
3 %
Band
Moderate
180-day horizon · target 2027-01-16 · 1,8× base rate
No acquirer candidates identified by the signal model.
Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 7 370 558 sh20 exercises · 21 grants13 insiders
- Director, Chief Investment Officer, 10% owner · Restricted Stock Units → Common StockDisposed 1 000 000grant · 2026-07-01
- Director · Restricted Stock Units → Common StockDisposed 75 000grant · 2026-07-01
- Director · Restricted Stock Units → Common StockDisposed 100 000grant · 2026-07-01
- Director · Restricted Stock Units → Common StockDisposed 100 000grant · 2026-07-01
- Director · Restricted Stock Units → Common StockDisposed 75 000grant · 2026-07-01
- Director · Restricted Stock Units → Common StockDisposed 75 000grant · 2026-07-01
- Director, CEO,CFO,Pres.,GC,Treas.&Sec. · Restricted Stock Units → Common StockDisposed 1 000 000grant · 2026-07-01
- Director · Restricted Stock Units → Common StockDisposed 75 000grant · 2026-07-01
- Director · Restricted Stock Units → Common StockDisposed 94 050exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 94 050exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 94 050exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 94 050exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 94 050exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 94 050exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 94 050exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 94 050exercise · 2026-03-13
- Director · Restricted Stock Units → Common StockDisposed 74 700exercise · 2026-03-13
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
How metrics are computed
- Price To Tangible Bookmarket_price / (tangible_book_value / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Return On Equitynet_income / total_equity
- Enterprise Valuemarket_cap - net_cash
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
Source documents
- CYPHERPUNK TECHNOLOGIES INC. company facts · 2026-07-26
- CYPHERPUNK TECHNOLOGIES INC. 10-Q 2026-05-14 · 2026-07-26
- CYPHERPUNK TECHNOLOGIES INC. 10-K 2026-03-16 · 2026-07-26
- CYPHERPUNK TECHNOLOGIES INC. 10-Q 2025-11-12 · 2026-07-26
- CYPHERPUNK TECHNOLOGIES INC. 10-Q 2025-08-14 · 2026-07-26
- 8-K (sec_8k_material) on CYPH · 2026-07-26
- Cypherpunk Technologies Inc Market data — analyst estimates · 2026-07-26
- CYPHERPUNK TECHNOLOGIES INC. HA canonical relationships · 2026-07-26
Ownership & reference
Top holders
- Investment Managers · as of 2025-12-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Doug E. OnsiPresident, Chief Executive Officer, Director
Insider activity
Net selling0 buys · 1 sellsnet -$43K11 insiders · last 365d
- Director · Common StockSold 60 000 @ $0,71$43K · 2026-03-26
- Director · Common StockOther 104 500 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 74 700 · 2026-03-13
- Director · Common StockOther 94 050 · 2026-03-13
- Director · Common StockOther 35 000 @ $1,20$42K · 2025-12-26
- Director · Common StockOther 83 000 · 2025-12-26
- Director · Common StockOther 2 136 · 2025-12-23
- Director · Common StockOther 712 · 2025-12-23
- Director, CEO,CFO,Pres.,GC,Treas.&Sec. · Common StockOther 2 136 · 2025-12-23
Short positioning
8.1Mshares short+5.6% vs prior
3.79days to cover
36.0%short of daily vol
47.6Kfails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
CYPHCanonical
Nasdaq · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskHigh
Liquidity riskHigh
Diluted share count is materially above the basic share count.
Filings reference going-concern or substantial-doubt language.
Source documents mention dilution or offering risk.
Relationship graph
This companySectorPartnersSubsidiaries
Evidence & claims
From filings & derived data- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -55.1%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 103.9%Derived (calculated)
- Return on equity (FY 2025-12-31): 3.3%Derived (calculated)
- Return on assets (FY 2025-12-31): 3.1%Derived (calculated)
- Current ratio (FY 2025-12-31): 35.56xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.06xDerived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 107.4%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 41.4%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 103.9%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 27.2%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -70.3%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 232.2%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -31.3%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 338.0%Derived (calculated)
- Current assets (annual): USD 162.08MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 0SEC XBRL filing
- Pre-tax income (annual): USD 10.08MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 0SEC XBRL filing
- Total operating expenses (annual): USD 41.07MSEC XBRL filing
- Cash & equivalents (annual): USD 14.04MSEC XBRL filing
- Total liabilities (annual): USD 9.68MSEC XBRL filing
- Net income (annual): USD 5MSEC XBRL filing
- R&D expense (annual): USD 25.67MSEC XBRL filing
- Operating income (annual): USD -41.07MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
2026-07-22 04:25 UTCFILINGMaterial 8-K
2026-07-01INSIDERLI WILLIAM disposed of 75.0k sh Restricted Stock Units — Director
2026-07-01INSIDERMashiach Nissim disposed of 75.0k sh Restricted Stock Units — Director
2026-07-01INSIDERMartin Patricia A. disposed of 75.0k sh Restricted Stock Units — Director
2026-07-01INSIDERMcEvoy William Patrick III disposed of 1.00M sh Restricted Stock Units — Director, Chief Investment Officer, 10% owner
2026-07-01INSIDERDietz Thomas John disposed of 100.0k sh Restricted Stock Units — Director
2026-07-01INSIDERRichard Christian M disposed of 75.0k sh Restricted Stock Units — Director
2026-07-01INSIDEROei Khing Djien disposed of 100.0k sh Restricted Stock Units — Director
2026-07-01INSIDERONSI DOUGLAS E disposed of 1.00M sh Restricted Stock Units — Director, CEO,CFO,Pres.,GC,Treas.&Sec.
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
2026-06-21 02:57 UTCHOLDERInstitutional holding changed
2026-06-21 02:57 UTCHOLDER1 institutional position change flagged
2026-03-31EARNINGSQuarterly results — Q4 2025 Net USD -77.2M
2026-03-26 00:00 UTCINSIDER39 insider transactions — 2026-03 19 derivative
2026-03-26 00:00 UTCINSIDER39 insider transactions — 2026-03 19 derivative
2026-03-26INSIDERMirabelli Christopher sold 60.0k sh — Director ~$43k
2026-03-13INSIDERDietz Thomas John transacted 104.5k sh — Director
2026-03-13INSIDERMirabelli Christopher transacted 74.7k sh — Director
2026-03-13INSIDERMirabelli Christopher transacted 94.0k sh — Director
2026-03-13INSIDEROei Khing Djien transacted 74.7k sh — Director
2026-03-13INSIDEROei Khing Djien transacted 94.0k sh — Director
2026-03-13INSIDERLI WILLIAM transacted 74.7k sh — Director
2026-03-13INSIDERLI WILLIAM transacted 94.0k sh — Director
2026-03-13INSIDERRichard Christian M transacted 74.7k sh — Director
2026-03-13INSIDERRichard Christian M transacted 94.0k sh — Director
2026-03-13INSIDERMashiach Nissim transacted 74.7k sh — Director
2026-03-13INSIDERMashiach Nissim transacted 94.0k sh — Director
2026-03-13INSIDERMartin Patricia A. transacted 74.7k sh — Director
2026-03-13INSIDERMartin Patricia A. transacted 94.0k sh — Director
2026-03-13INSIDERSchilsky Richard transacted 74.7k sh — Director
2026-03-13INSIDERSchilsky Richard transacted 94.0k sh — Director
2026-03-13INSIDERLOSCALZO JOSEPH transacted 74.7k sh — Director
Showing the 40 most recent of 70 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data
Premium coverage